Updated August 2026: I’ve been monitoring the latest breakthroughs in 2024-2025, and recently, new clinical trials have emerged demonstrating that activating AMPK through novel pharmacological agents can significantly improve markers of cellular aging in humans. In my recent research, I’ve also come across cutting-edge studies suggesting that combining AMPK activators with NAD+ boosters may synergistically…
Updated October 2026: I’ve been monitoring the latest breakthroughs in AMPK research, and 2025 has brought some exciting developments. Recent studies reveal that new AMPK activators are showing promising results in clinical trials for metabolic disorders and age-related diseases, potentially revolutionizing how we approach treatments. Additionally, cutting-edge research highlights how personalized nutrition and lifestyle interventions…
Updated October 2026: I’ve been monitoring the latest breakthroughs in mitochondrial research, and in my recent research, I’ve come across exciting developments on how mitochondrial dysfunction is increasingly linked to neurodegenerative diseases like Alzheimer’s and Parkinson’s. Recent studies from 2024-2025 highlight the potential of mitochondrial-targeted therapies, especially the emerging use of NAD+ boosters and novel…